234 related articles for article (PubMed ID: 29446917)
1. Mapping the mAb Aggregation Propensity Using Self-Interaction Chromatography as a Screening Tool.
Hedberg SHM; Lee D; Mishra Y; Haigh JM; Williams DR
Anal Chem; 2018 Mar; 90(6):3878-3885. PubMed ID: 29446917
[TBL] [Abstract][Full Text] [Related]
2. The second virial coefficient as a predictor of protein aggregation propensity: A self-interaction chromatography study.
Quigley A; Williams DR
Eur J Pharm Biopharm; 2015 Oct; 96():282-90. PubMed ID: 26259782
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions.
Nicoud L; Jagielski J; Pfister D; Lazzari S; Massant J; Lattuada M; Morbidelli M
J Phys Chem B; 2016 Apr; 120(13):3267-80. PubMed ID: 27007829
[TBL] [Abstract][Full Text] [Related]
5. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
Zidar M; Šušterič A; Ravnik M; Kuzman D
Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
[TBL] [Abstract][Full Text] [Related]
6. Relating Protein-Protein Interactions and Aggregation Rates From Low to High Concentrations.
Ghosh R; Calero-Rubio C; Saluja A; Roberts CJ
J Pharm Sci; 2016 Mar; 105(3):1086-96. PubMed ID: 26928400
[TBL] [Abstract][Full Text] [Related]
7. Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass.
Neergaard MS; Nielsen AD; Parshad H; Van De Weert M
J Pharm Sci; 2014 Jan; 103(1):115-27. PubMed ID: 24282022
[TBL] [Abstract][Full Text] [Related]
8. Effects of Protein Conformation, Apparent Solubility, and Protein-Protein Interactions on the Rates and Mechanisms of Aggregation for an IgG1Monoclonal Antibody.
Kalonia C; Toprani V; Toth R; Wahome N; Gabel I; Middaugh CR; Volkin DB
J Phys Chem B; 2016 Jul; 120(29):7062-75. PubMed ID: 27380437
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association.
Sudrik CM; Cloutier T; Mody N; Sathish HA; Trout BL
Pharm Res; 2019 May; 36(8):109. PubMed ID: 31127417
[TBL] [Abstract][Full Text] [Related]
10. First-order nucleation and subsequent growth promote liquid-liquid phase separation of a model IgG1 mAb.
Tian Z; Xu L; Zhang N; Qian F
Int J Pharm; 2020 Oct; 588():119681. PubMed ID: 32721563
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Dynamic Light Scattering and Size Exclusion High Performance Liquid Chromatography for Monitoring the Effect of pH on Stability of Biopharmaceuticals.
Al-Ghobashy MA; Mostafa MM; Abed HS; Fathalla FA; Salem MY
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():1-9. PubMed ID: 28578190
[TBL] [Abstract][Full Text] [Related]
12. Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosity.
Cloutier TK; Sudrik C; Mody N; Hasige SA; Trout BL
MAbs; 2020; 12(1):1816312. PubMed ID: 32938318
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput method for detection of protein self-association and second virial coefficient using size-exclusion chromatography through simultaneous measurement of concentration and scattered light intensity.
Bajaj H; Sharma VK; Kalonia DS
Pharm Res; 2007 Nov; 24(11):2071-83. PubMed ID: 17577643
[TBL] [Abstract][Full Text] [Related]
14. Relation of Colloidal and Conformational Stabilities to Aggregate Formation in a Monoclonal Antibody.
Oyama H; Koga H; Tadokoro T; Maenaka K; Shiota A; Yokoyama M; Noda M; Torisu T; Uchiyama S
J Pharm Sci; 2020 Jan; 109(1):308-315. PubMed ID: 31669120
[TBL] [Abstract][Full Text] [Related]
15. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
[TBL] [Abstract][Full Text] [Related]
16. Role of cosolutes in the aggregation kinetics of monoclonal antibodies.
Nicoud L; Sozo M; Arosio P; Yates A; Norrant E; Morbidelli M
J Phys Chem B; 2014 Oct; 118(41):11921-30. PubMed ID: 25243487
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Protein Aggregation in High Concentration Protein Solutions Utilizing Protein-Protein Interactions Determined by Low Volume Static Light Scattering.
Hofmann M; Winzer M; Weber C; Gieseler H
J Pharm Sci; 2016 Jun; 105(6):1819-1828. PubMed ID: 27157445
[TBL] [Abstract][Full Text] [Related]
18. Trimerization Dictates Solution Opalescence of a Monoclonal Antibody.
Yang TC; Langford AJ; Kumar S; Ruesch JC; Wang W
J Pharm Sci; 2016 Aug; 105(8):2328-37. PubMed ID: 27373839
[TBL] [Abstract][Full Text] [Related]
19. The missing piece in the puzzle: Prediction of aggregation via the protein-protein interaction parameter A
Koepf E; Schroeder R; Brezesinski G; Friess W
Eur J Pharm Biopharm; 2018 Jul; 128():200-209. PubMed ID: 29723667
[TBL] [Abstract][Full Text] [Related]
20. Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.
Neergaard MS; Kalonia DS; Parshad H; Nielsen AD; Møller EH; van de Weert M
Eur J Pharm Sci; 2013 Jun; 49(3):400-10. PubMed ID: 23624326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
